Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 30, 2012

NEW YORK (GenomeWeb News) – WaferGen said this week that it has terminated the employment of senior executives Mona Chadha and Donald Huffman. Chadha was chief operating officer, executive VP of marketing and business development, and secretary of the company, and Huffman was company CFO. Wafergen said it has appointed Director of Finance John Harland to assume the role of interim CFO and VP of finance.

Molecular diagnostics firm Response Genetics has tapped Stephanie Astrow to be VP of research and development. Astrow most recently was scientific director for oncology at Quest Diagnostics, where she worked to introduce new assays and services and coordinated with pharmaceutical companies to develop companion diagnostics. She also served as VP and director of oncology at Pathway Diagnostics and VP and scientific director at Impath.

The University of Pennsylvania has named Benjamin Garcia a Presidential Term Professor of Biochemistry and Biophysics in Penn's Perelman School of Medicine. The Presidential Term Professorship is funded in part by a $2 million award to Penn from the Pew Charitable Trusts. Garcia is currently an assistant professor of molecular biology at Princeton University, and before that he was a post-doctoral fellow at the Institute for Genomic Biology at the University of Illinois.

Michael Porter has resigned his position on the board of directors of Thermo Fisher Scientific, the company said in a recent filing with the US Securities and Exchange Commission. Porter was first elected to the board in 2001. He was a member of the company's nominating and corporate governance and strategy and finance committees.

Agilent Technologies has appointed Solange Glaize to serve as VP and chief accounting officer, effective immediately. Glaize has already held various posts at Agilent, including senior director of finance for the life sciences solutions unit, and VP of finance and group CFO of the Life Sciences Group. Glaize will receive an increase in her base salary to $285,000.

Conceptus has named Lori Ciano as its executive vice president of human resources. Ciano joins Conceptus from Affymetrix, where she was senior vice president of human resources. Before that, she was vice president of human resources at Novellus Systems. Ciano also worked for Varian Associates for 20 years in a variety of customer service, marketing, and business development positions

The American Medical Informatics Association has tapped Kevin Fickenscher as president and CEO of the organization. Fickenscher will officially start his new role on April 1. He replaces Ted Shortliffe, who announced his decision to step down from the position several months ago.

University of Rochester Medical Center said this week that Hulin Wu, a professor of biostatistics and computational biology, will serve as the founding director of its newly established Center for Integrative Bioinformatics and Experimental Mathematics.

The new center is part of the university's department of biostatistics and computational biology and will work on integrating and strengthening current biostatistics, bioinformatics, and computational biology resources at the center.

IntegenX said this week that Louis Grever has joined the company's board of directors. Grever is a former executive assistant director of the Science and Technology Branch of the Federal Bureau of Investigation, where he served for 24 years in various roles.

DNA2.0 announced that Howard Simon has been named COO and general counsel. He joins the synthetic gene vendor from InterMune, where he served as SVP, human resources and corporate services, associate general counsel, and chief compliance officer from 2004 to 2012.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.